JP2008011860A - 大腸癌診断方法および診断キット - Google Patents
大腸癌診断方法および診断キット Download PDFInfo
- Publication number
- JP2008011860A JP2008011860A JP2007175132A JP2007175132A JP2008011860A JP 2008011860 A JP2008011860 A JP 2008011860A JP 2007175132 A JP2007175132 A JP 2007175132A JP 2007175132 A JP2007175132 A JP 2007175132A JP 2008011860 A JP2008011860 A JP 2008011860A
- Authority
- JP
- Japan
- Prior art keywords
- rar
- cancer
- colorectal cancer
- gene
- chromosome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010009944 Colon cancer Diseases 0.000 title claims abstract description 62
- 208000001333 Colorectal Neoplasms Diseases 0.000 title claims abstract description 59
- 238000009007 Diagnostic Kit Methods 0.000 title claims abstract description 12
- 238000003745 diagnosis Methods 0.000 title claims description 7
- 238000000034 method Methods 0.000 title abstract description 14
- 210000000349 chromosome Anatomy 0.000 claims abstract description 33
- 230000008859 change Effects 0.000 claims abstract description 30
- 230000014509 gene expression Effects 0.000 claims abstract description 29
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 25
- 102000044209 Tumor Suppressor Genes Human genes 0.000 claims abstract description 19
- 108700025716 Tumor Suppressor Genes Proteins 0.000 claims abstract description 19
- 238000004393 prognosis Methods 0.000 claims abstract description 13
- 230000008034 disappearance Effects 0.000 claims description 7
- 102100033561 Calmodulin-binding transcription activator 1 Human genes 0.000 claims description 6
- 101000945309 Homo sapiens Calmodulin-binding transcription activator 1 Proteins 0.000 claims description 6
- 230000007423 decrease Effects 0.000 claims description 3
- 238000002405 diagnostic procedure Methods 0.000 abstract description 9
- 206010028980 Neoplasm Diseases 0.000 description 25
- 101150005627 CAMTA1 gene Proteins 0.000 description 16
- 201000011510 cancer Diseases 0.000 description 13
- 238000004458 analytical method Methods 0.000 description 12
- 108020004414 DNA Proteins 0.000 description 11
- 210000001519 tissue Anatomy 0.000 description 11
- 230000004083 survival effect Effects 0.000 description 9
- 208000029742 colonic neoplasm Diseases 0.000 description 8
- 230000003321 amplification Effects 0.000 description 7
- 238000003199 nucleic acid amplification method Methods 0.000 description 7
- 108700020796 Oncogene Proteins 0.000 description 6
- 102000043276 Oncogene Human genes 0.000 description 6
- 230000005856 abnormality Effects 0.000 description 6
- 238000009396 hybridization Methods 0.000 description 6
- 208000037051 Chromosomal Instability Diseases 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 230000002068 genetic effect Effects 0.000 description 5
- 238000007838 multiplex ligation-dependent probe amplification Methods 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000002759 chromosomal effect Effects 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 208000032818 Microsatellite Instability Diseases 0.000 description 3
- 238000011529 RT qPCR Methods 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 206010069754 Acquired gene mutation Diseases 0.000 description 2
- 208000015634 Rectal Neoplasms Diseases 0.000 description 2
- 231100000504 carcinogenesis Toxicity 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 230000037442 genomic alteration Effects 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 206010038038 rectal cancer Diseases 0.000 description 2
- 201000001275 rectum cancer Diseases 0.000 description 2
- 238000000611 regression analysis Methods 0.000 description 2
- 230000037439 somatic mutation Effects 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 102100034613 Annexin A2 Human genes 0.000 description 1
- 102100031936 Anterior gradient protein 2 homolog Human genes 0.000 description 1
- -1 BLC11A Proteins 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 102100040934 Claudin-22 Human genes 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 102100035429 Cystathionine gamma-lyase Human genes 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 102100037024 E3 ubiquitin-protein ligase XIAP Human genes 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 108700024394 Exon Proteins 0.000 description 1
- 102100027279 FAS-associated factor 1 Human genes 0.000 description 1
- 102100024185 G1/S-specific cyclin-D2 Human genes 0.000 description 1
- 101150112014 Gapdh gene Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 101000924474 Homo sapiens Annexin A2 Proteins 0.000 description 1
- 101000775021 Homo sapiens Anterior gradient protein 2 homolog Proteins 0.000 description 1
- 101000749338 Homo sapiens Claudin-22 Proteins 0.000 description 1
- 101000737584 Homo sapiens Cystathionine gamma-lyase Proteins 0.000 description 1
- 101000804865 Homo sapiens E3 ubiquitin-protein ligase XIAP Proteins 0.000 description 1
- 101000914654 Homo sapiens FAS-associated factor 1 Proteins 0.000 description 1
- 101000980741 Homo sapiens G1/S-specific cyclin-D2 Proteins 0.000 description 1
- 101001040875 Homo sapiens Glucosidase 2 subunit beta Proteins 0.000 description 1
- 101001053708 Homo sapiens Inhibitor of growth protein 2 Proteins 0.000 description 1
- 101001011393 Homo sapiens Interferon regulatory factor 2 Proteins 0.000 description 1
- 101000780205 Homo sapiens Long-chain-fatty-acid-CoA ligase 5 Proteins 0.000 description 1
- 101000593405 Homo sapiens Myb-related protein B Proteins 0.000 description 1
- 101001103036 Homo sapiens Nuclear receptor ROR-alpha Proteins 0.000 description 1
- 101000730665 Homo sapiens Phospholipase D1 Proteins 0.000 description 1
- 101001117517 Homo sapiens Prostaglandin E2 receptor EP3 subtype Proteins 0.000 description 1
- 101000817237 Homo sapiens Protein ECT2 Proteins 0.000 description 1
- 101000716803 Homo sapiens Protein SCO1 homolog, mitochondrial Proteins 0.000 description 1
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 1
- 101000889732 Homo sapiens Tyrosine-protein kinase Tec Proteins 0.000 description 1
- 101000743490 Homo sapiens V-set and immunoglobulin domain-containing protein 2 Proteins 0.000 description 1
- 102100024067 Inhibitor of growth protein 2 Human genes 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 102100029838 Interferon regulatory factor 2 Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 102100034318 Long-chain-fatty-acid-CoA ligase 5 Human genes 0.000 description 1
- 101000964266 Loxosceles laeta Dermonecrotic toxin Proteins 0.000 description 1
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
- 102100034670 Myb-related protein B Human genes 0.000 description 1
- 102100038895 Myc proto-oncogene protein Human genes 0.000 description 1
- 206010061309 Neoplasm progression Diseases 0.000 description 1
- 102100039614 Nuclear receptor ROR-alpha Human genes 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 102100032967 Phospholipase D1 Human genes 0.000 description 1
- 102100024447 Prostaglandin E2 receptor EP3 subtype Human genes 0.000 description 1
- 102100040437 Protein ECT2 Human genes 0.000 description 1
- 102100020866 Protein SCO1 homolog, mitochondrial Human genes 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- 108010040002 Tumor Suppressor Proteins Proteins 0.000 description 1
- 102000001742 Tumor Suppressor Proteins Human genes 0.000 description 1
- 108010083162 Twist-Related Protein 1 Proteins 0.000 description 1
- 102100030398 Twist-related protein 1 Human genes 0.000 description 1
- 102100040177 Tyrosine-protein kinase Tec Human genes 0.000 description 1
- 210000001766 X chromosome Anatomy 0.000 description 1
- 208000036878 aneuploidy Diseases 0.000 description 1
- 238000012098 association analyses Methods 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 239000008004 cell lysis buffer Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000003989 dielectric material Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 1
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000006607 hypermethylation Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 238000012775 microarray technology Methods 0.000 description 1
- 230000033607 mismatch repair Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 1
- 201000011682 nervous system cancer Diseases 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 238000010837 poor prognosis Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 201000003858 rectosigmoid cancer Diseases 0.000 description 1
- 208000028165 rectosigmoid carcinoma Diseases 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000005751 tumor progression Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020060061741A KR101401749B1 (ko) | 2006-07-03 | 2006-07-03 | 대장암 진단 방법 및 진단키트 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008011860A true JP2008011860A (ja) | 2008-01-24 |
| JP2008011860A5 JP2008011860A5 (enExample) | 2008-04-17 |
Family
ID=39069514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007175132A Pending JP2008011860A (ja) | 2006-07-03 | 2007-07-03 | 大腸癌診断方法および診断キット |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP2008011860A (enExample) |
| KR (1) | KR101401749B1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011067130A (ja) * | 2009-09-25 | 2011-04-07 | Yamaguchi Univ | 大腸癌の予後予測方法 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100976218B1 (ko) | 2008-05-26 | 2010-08-17 | 한국표준과학연구원 | 비행시간이차이온질량분광법을 이용한 질병의 진단 방법,질병 지표의 스크린 방법, 및 질병 지표 |
-
2006
- 2006-07-03 KR KR1020060061741A patent/KR101401749B1/ko not_active Expired - Fee Related
-
2007
- 2007-07-03 JP JP2007175132A patent/JP2008011860A/ja active Pending
Non-Patent Citations (11)
| Title |
|---|
| JPN6010021275, Ｃｌｉｎ． Ｃａｎｃｅｒ Ｒｅｓ．， ｖｏｌ． １１， ｐａｇｅｓ １１１９−１１２８ （２００５） * |
| JPN6010021277, Ｊ． Ｂｉｏｌ． Ｃｈｅｍ．， ｖｏｌ． ２７７， ｐａｇｅｓ ２１８５１−２１８６１ （２００２） * |
| JPN6010021280, Ｓｅｍｉｎ． Ｃａｎｃｅｒ Ｂｉｏｌ．， ｖｏｌ． １５， ｐａｇｅｓ ４８４−４９３ （２００５） * |
| JPN6010021281, Ｂｒ． Ｊ． Ｃａｎｃｅｒ， ｖｏｌ． ７９， ｐａｇｅｓ １４６８−１４７４ （１９９９） * |
| JPN6010021284, Ｇａｓｔｒｏｅｎｔｅｒｏｌｏｇｙ， ｖｏｌ． １３１， ｐａｇｅｓ １９１３−１９２４ （Ｄｅｃ． ２００６） * |
| JPN6010052855, Ｈｉｓｔｏｐａｔｈｏｌｏｇｙ， ｖｏｌ． ４３， ｐａｇｅｓ ３２３−３３１ （２００３） * |
| JPN6010052856, 第６４回日本癌学会学術総会記事，第２７１−２７２頁，ＰＡ２−０５５８（２００５年） * |
| JPN6010052857, 第６０回日本癌学会学術総会記事，第２１２頁，５８４（２００１年） * |
| JPN6010052858, 日本外科学会雑誌，第１０４巻，臨時増刊号，第３４１頁，ＰＳ１０１２−５（２００３年） * |
| JPN6010052859, 日本外科学会雑誌，第１０１巻，臨時増刊号，第２０８頁，ＰＰ−４（２０００年） * |
| JPN6010052860, 日本外科学会雑誌，第１０７巻，臨時増刊号，第２０１頁，ＳＦ−００８−２（２００６年３月） * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011067130A (ja) * | 2009-09-25 | 2011-04-07 | Yamaguchi Univ | 大腸癌の予後予測方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20080003472A (ko) | 2008-01-08 |
| KR101401749B1 (ko) | 2014-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kang et al. | Gain at chromosomal region 5p15. 33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer | |
| Choi et al. | Gene expression profiles in squamous cell cervical carcinoma using array-based comparative genomic hybridization analysis | |
| Kim et al. | Recurrent genomic alterations with impact on survival in colorectal cancer identified by genome-wide array comparative genomic hybridization | |
| US7034144B2 (en) | Molecular detection of chromosome aberrations | |
| Michels et al. | ArrayCGH‐based classification of neuroblastoma into genomic subgroups | |
| Chattopadhyay et al. | Genome-wide analysis of chromosomal alterations in patients with esophageal squamous cell carcinoma exposed to tobacco and betel quid from high-risk area in India | |
| US8980556B2 (en) | High resolution melting analysis as a prescreening tool | |
| Jehan et al. | In-situ hybridization as a molecular tool in cancer diagnosis and treatment | |
| Wang et al. | Somatic mutation screening using archival formalin-fixed, paraffin-embedded tissues by fluidigm multiplex PCR and Illumina sequencing | |
| EP3888093A1 (en) | Differential methylation | |
| Peluso et al. | Lymph node fine-needle cytology: beyond flow cytometry | |
| US7939255B2 (en) | Diagnostic methods for colorectal cancer | |
| Wiech et al. | Genome-wide analysis of genetic alterations in Barrett's adenocarcinoma using single nucleotide polymorphism arrays | |
| US20080274909A1 (en) | Kits and Reagents for Use in Diagnosis and Prognosis of Genomic Disorders | |
| Hughes et al. | The use of whole genome amplification to study chromosomal changes in prostate cancer: insights into genome-wide signature of preneoplasia associated with cancer progression | |
| Kang et al. | Genetic alterations in primary gastric carcinomas correlated with clinicopathological variables by array comparative genomic hybridization | |
| WO2014127267A1 (en) | Methods and tools for the diagnosis and prognosis of urogenital cancers | |
| Poniah et al. | Genome-wide copy number analysis reveals candidate gene loci that confer susceptibility to high-grade prostate cancer | |
| Romeo et al. | Heterogeneous and complex rearrangements of chromosome arm 6q in chondromyxoid fibroma: delineation of breakpoints and analysis of candidate target genes | |
| Liang et al. | Loss of SFRP1 expression is a key progression event in gastrointestinal stromal tumor pathogenesis | |
| JP5865241B2 (ja) | 肉腫の予後分子署名およびその使用 | |
| JP2008011860A (ja) | 大腸癌診断方法および診断キット | |
| CN102216471B (zh) | 膀胱癌的尿检测方法 | |
| EP3625370A1 (en) | Composite epigenetic biomarkers for accurate screening, diagnosis and prognosis of colorectal cancer | |
| Kang et al. | AMY2A: a possible tumor-suppressor gene of 1p21. 1 loss in gastric carcinoma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080208 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100420 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100713 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100716 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100818 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100914 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101214 |
|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20101214 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20110111 |